BOM Capital
116
4M
95
2.83
17
0.18
8
- Stages of investment
- Areas of investment
Summary
BOM Capital is the famous VC, which was founded in 1983. The leading representative office of defined VC is situated in the Tilburg. The fund was located in Europe if to be more exact in The Netherlands.
Opposing the other organizations, this BOM Capital works on 20 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2015. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the BOM Capital, startups are often financed by Thuja Capital, EASME - EU Executive Agency for SMEs, Technology Development Fund. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, TIIN Capital, BioGeneration Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, BNP Paribas Private Equity, henQ.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Protix Biosystems, ULU.
Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 116
- Lead investments
- 17
- Exits
- 8
- Rounds per year
- 2.83
- Follow on index
- 0.18
- Investments by industry
- Manufacturing (21)
- Health Care (18)
- Medical (17)
- Medical Device (17)
- Biotechnology (17) Show 122 more
- Investments by region
-
- Netherlands (84)
- United States (9)
- The Netherlands (18)
- United Kingdom (1)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 48M
- Group Appearance index
- 0.59
- Avg. company exit year
- 19
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Globe Protocol | 13 Feb 2023 | Information Technology, Information Services | Seed | 590K | Eindhoven, Noord-Brabant, The Netherlands |
| Immagene | 24 Apr 2024 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 23M | Noord-Holland, Amsterdam, The Netherlands |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.